Taken together, our results show that pKAL enhances the anticancer effect of β-Lap in HCT116 colorectal cancer cells containing OxPt-R by downregulating TERT, CD44, EGFR, and upregulated oxaliplatin resistance-related proteins. This evidence concerns the gene CD44 and colorectal cancer.